COMPASS Pathways granted fifth US patent for crystalline psilocybin
23 nov. 2021 07h00 HE
|
COMPASS Pathways
London, UK - 23 November 2021 COMPASS Pathways plc (Nasdaq: CMPS) (“COMPASS”), a mental health care company dedicated to accelerating patient access to evidence-based innovation in mental health,...